Presence and short‐term persistence of SARS‐CoV‐2 neutralizing antibodies in COVID‐19 convalescent plasma donors
Explore this paper's citation graph
Summary
In March 2020, the Food and Drug Administration (FDA) approved use of COVID‐19 convalescent plasma (CCP) as an investigational new drug for treatment of CO VID‐19.
- Type
- preprint
- Published
- 2020-09-03
- Cited by
- 11
- References
- 44
- Access
- Open access
- OpenAlex
- https://openalex.org/W3082675321
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:221491695
Keywords
Titer, Virology, Antibody, Neutralizing antibody, Convalescent plasma
References
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
- Protein levels and plasmapheresis intensity
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS Coronavirus
- Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
- Duration of Antibody Responses after Severe Acute Respiratory Syndrome
- Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
- Structural basis of receptor recognition by SARS-CoV-2
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
- Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
- Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
- Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
- Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
- Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019
- Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Cited by
- Passive Immunity Should and Will Work for COVID-19 for Some Patients
- Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccination
- Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma
- Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
- A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies
- Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications
- Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
- An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
- Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature
- The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2.
- Role of Immunochromatographic Techniques in the Diagnosis of COVID-19
Related papers
- Neutralization Assay for SARS-CoV-2 Infection: Plaque Reduction Neutralization Test.
- Serum Neutralization Assay Can Efficiently Replace Plaque Reduction Neutralization Test for Detection and Quantitation of West Nile Virus Antibodies in Human and Animal Serum Samples
- Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus.
- Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020
- IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
- Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.
- Colorimetric neutralization test for herpes simplex, with observations on neutralizing and complement-fixing antibody levels in human sera.